Table 1 Clinical and molecular characteristics of 98 patients with rectal carcinoma
Clinical and molecular characteristics | No patients n=98 (%) |
|---|---|
Sex | Â |
Male | 50 (51) |
Female | 48 (49) |
Age. y median | 68 (35–88) |
Distance to anal verge. cm | Â |
≥10 | 25 (25.5) |
5≤ <10 | 26 (26.5) |
<5 | 40 (41.8) |
Not avaibale | 7 (7.2) |
Type of resection | Â |
Low anterior | 8 (8.1) |
Abdominoperineal | 90 (91.9) |
CRM | Â |
Negative | 88 (89.8) |
Positive | 3 (3.1) |
Not avaiballe | 7 (7.1) |
Differentiation | Â |
Well | 15 (15.1) |
Moderate | 51 (52.1) |
Poor | 10 (10.3) |
Not avaibale | 22 (22.5) |
TNM stage | Â |
I | 6 (6.1) |
II | 86 (87.8) |
II | 6 (6.1) |
KRAS mutation | Â |
Yes | 23(23.5%) |
No | 75 (76.5) |
BRAF mutation | Â |
Yes | 2 (2%) |
No | 96 (98%) |
PIK3CA mutation | Â |
Yes | 4 (4%) |
No | 94 (96%) |
Local recurrence | Â |
Negative | 90 (91.8) |
Positive | 8 (8.2) |
Distant metastasis | Â |
Negative | 81 (82.6) |
Positive | 17 (17.4) |